GPR137B and Lassa fever: Another study also showed that the deletion of lncRNA Gpr137b-ps inhibited HSC activation and ameliorated LF in mice by regulating miR-200a-3p, providing a new therapeutic target for patients with LF (Liao et al., 2021).